Cart
sales@molnova.com
Home - Products - Metabolic Enzyme/Protease - FXR - DY-268

DY-268

CAS No. 1609564-75-1

DY-268( —— )

Catalog No. M23707 CAS No. 1609564-75-1

DY-268 is a compound based on trisubstituted pyrazolamide without any FXR agonist activity and cytotoxicity and can be used as an effective FXR antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 85 In Stock
5MG 76 In Stock
10MG 122 In Stock
25MG 245 In Stock
50MG 445 In Stock
100MG 641 In Stock
200MG Get Quote In Stock
500MG 1376 In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    DY-268
  • Note
    Research use only, not for human use.
  • Brief Description
    DY-268 is a compound based on trisubstituted pyrazolamide without any FXR agonist activity and cytotoxicity and can be used as an effective FXR antagonist.
  • Description
    DY-268 is a compound based on trisubstituted pyrazolamide without any FXR agonist activity and cytotoxicity and can be used as an effective FXR antagonist (IC50 = 7.5 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    FXR
  • Recptor
    FXR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1609564-75-1
  • Formula Weight
    560.66
  • Molecular Formula
    C30H32N4O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:Soluble; Water: Insoluble
  • SMILES
    Cc(cc1)ccc1-c1nn(Cc2cc(OC)ccc2)cc1C(Nc1cc(S(N2CCOCC2)(=O)=O)c(C)cc1)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Roman-Lopez J, et al. Effect of the chemical impurities on the luminescence emission of natural apatites. Spectrochim Acta A Mol Biomol Spectrosc. 2014 May 21;126:142-7.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Ursodeoxycholic acid...

    Ursodeoxycholic acid sodium is a naturally occurring secondary bile acid with anti-inflammatory and cytoprotective activities. Ursodeoxycholic acid sodium acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors,

  • Osocimab

    Osocimab (BAY 1213790) is a potent anti-FXIa antibody with a Ki value of 2.4 nM and an EC50 value of 0.2 nM.

  • Fexaramine

    A potent, specific FXR agonist with EC50 of 25 nM, more efficacious ligand for FXR than GW4064.

Sign In Join Free